NBW Capital
MDGL icon

NBW Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

NBW Capital’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,563
Closed -$940K – 83
2014
Q2 		$940K Sell
6,563
-356
-5% -$52K 0.21% 69
2014
Q1 		$1.04M Sell
6,919
-4,607
-40% -$907K 0.27% 65
2013
Q4 		$2.11M Sell
11,526
-37
-0.3% -$6.78K 0.34% 68
2013
Q3 		$2.55M Sell
11,563
-97
-0.8% -$20.6K 0.45% 61
2013
Q2 		$2.04M Buy
+11,660
New +$3.04M 0.39% 66

Other funds holding MDGL

Caxton Corporation
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jefferies Group
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NBW Capital's MDGL Position: Q3 2014 in Review

NBW Capital sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2014, closing a stake of 6,563 shares — an estimated $940K sold.

NBW Capital first reported a position in MDGL in Q2 2013 and held it in 5 quarters. The position peaked at $2.55M in Q3 2013. 92 funds tracked by Wall St. Rank hold MDGL as of Q3 2014.

  • NBW Capital reported no remaining Madrigal Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • NBW Capital sold 6,563 Madrigal Pharmaceuticals shares in Q3 2014, an estimated $940K.
  • NBW Capital first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • NBW Capital's Madrigal Pharmaceuticals position peaked at $2.55M in Q3 2013.
  • 92 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2014.

Based on NBW Capital's 13F filing for Q3 2014, filed 17 Nov 2014.